A Phase 2 Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors
Status:
Recruiting
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
A Multi-center, Non-Randomized, Open-Label Phase 2 Basket Clinical Trial to Evaluate ICP-723
in Patients with Advanced Solid Tumors or Primary Central Nervous System Tumors